These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2506673

  • 1. Enhanced cancer metastasis after monocrotaline-induced lung injury.
    Vincic L, Orr FW, Warner DJ, Suyama KL, Kay JM.
    Toxicol Appl Pharmacol; 1989 Sep 01; 100(2):259-70. PubMed ID: 2506673
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Early indications of monocrotaline pyrrole-induced lung injury in rats.
    Schultze AE, Wagner JG, White SM, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jun 01; 109(1):41-50. PubMed ID: 2038748
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
    Gillespie MN, Olson JW, Hennig B, Cohen DA, McClain CJ, Goldblum SE.
    Toxicol Appl Pharmacol; 1989 Mar 15; 98(1):134-43. PubMed ID: 2494779
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
    Todd L, Mullen M, Olley PM, Rabinovitch M.
    Pediatr Res; 1985 Jul 15; 19(7):731-7. PubMed ID: 3161000
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    White SM, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1989 Jun 15; 99(2):302-13. PubMed ID: 2734793
    [Abstract] [Full Text] [Related]

  • 10. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
    Bruner LH, Johnson K, Carpenter LJ, Roth RA.
    J Toxicol Environ Health; 1987 Jun 15; 21(1-2):205-17. PubMed ID: 3573071
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Quantification of metastatic tumor growth in bleomycin-injured lungs.
    Orr FW, Adamson IY, Young L.
    Clin Exp Metastasis; 1986 Jun 15; 4(2):105-16. PubMed ID: 2424657
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.
    Ilkiw R, Todorovich-Hunter L, Maruyama K, Shin J, Rabinovitch M.
    Circ Res; 1989 Apr 15; 64(4):814-25. PubMed ID: 2495195
    [Abstract] [Full Text] [Related]

  • 18. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
    Shubat PJ, Hubbard AK, Huxtable RJ.
    J Toxicol Environ Health; 1989 Apr 15; 28(4):445-60. PubMed ID: 2531804
    [Abstract] [Full Text] [Related]

  • 19. Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension.
    Hilliker KS, Bell TG, Lorimer D, Roth RA.
    Am J Physiol; 1984 Jun 15; 246(6 Pt 2):H747-53. PubMed ID: 6742140
    [Abstract] [Full Text] [Related]

  • 20. Complement is not involved in monocrotaline pyrrole-induced pulmonary injury.
    Bruner LH, Johnson KJ, Till GO, Roth RA.
    Am J Physiol; 1988 Feb 15; 254(2 Pt 2):H258-64. PubMed ID: 3344816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.